Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168 USD | +0.57% | +1.12% | -6.56% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.56% | 9.33B | |
-4.02% | 184B | |
-0.75% | 108B | |
-2.97% | 67.82B | |
+4.49% | 51.05B | |
+9.09% | 44.67B | |
+3.40% | 41.78B | |
+3.12% | 26.78B | |
+4.10% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M, vs. Street Est of $117M